logo
Sign In
Farxiga vs. GlyxambiBerinert vs. CinryzeEmgality vs. QuliptaFarxiga vs. InvokanaFirazyr vs. SajazirGlyxambi vs. InvokanaInvokamet vs. SynjardyOpzelura vs. DupixentOrencia vs. RinvoqQulipta vs. VyeptiStelara vs. TremfyaSynjardy vs. VictozaTaltz vs. BimzelxVyepti vs. Nurtec ODTView all Comparisons
ADHD drugsAnxiety drugsAsthma drugsAtopic dermatitis drugsDepression drugsHeart failure drugsHypertension drugsLymphoma drugsOsteoarthritis drugsRheumatoid arthritis drugsRosacea drugsSchizophrenia drugsType 2 Diabetes drugsView all Indications
Bayer drugsAbbVie drugsAstraZeneca drugsEli Lilly and Company drugsGenetech drugsGlaxoSmithKline (GSK) drugsNovartis drugsPfizer drugsTakeda Pharmaceuticals drugsTeva Pharmaceuticals drugsAmgen drugsView all Manufacturers
Beta-Adrenergic BlockerAngiotensin Converting Enzyme InhibitorAngiotensin 2 Receptor BlockerCalcium Channel BlockerDiureticsHMG-CoA Reductase InhibitorProton Pump InhibitorSelective Serotonin Reuptake InhibitorNorepinephrine Reuptake InhibitorBenzodiazepinesOpioid AgonistsNonsteroidal Anti-inflammatory DrugsAntiepileptic AgentsAntipsychoticsAntihistaminesView all Classes
Wegovy®Ozempic®Mounjaro®Zepbound®Jardiance®Farxiga®Dupixent®Trulicity®Lyrica®Lipitor®Effexor®Concerta®Depakote®Trintellix®Rexulti®Rinvoq®Verzenio®Taltz®
PrescriberPoint
HIPAA Logo
HIPAA COMPLIANT
SOC 2 Logo
Soc 2 Type II
PrescriberPoint
HIPAA Logo
HIPAA COMPLIANT
SOC 2 Logo
Soc 2 Type II
For ProvidersRequest DemoJoin Research Panel
Prescribing toolsPrescribing InfoCoverageSavingsPatient ResourcesA-Z IndicationsCompare Drugs
CompanyPartnershipsAboutCareersContact Us
Get the latest insights in your inbox
  • Terms and Conditions
  • Privacy Policy
  • © 2026 PrescriberPoint. All Rights Reserved.
    1. Home
    2. Indications
    3. Localizationrelated Focal Partial Idiopathic Epilepsy And Epileptic Syndromes With Seizures Of Localized Onset

    Medications for Localizationrelated Focal Partial Idiopathic Epilepsy And Epileptic Syndromes With Seizures Of Localized Onset

    FiltersReset Filters
    13 results

    • aptiom

      (ESLICARBAZEPINE ACETATE)
      Sumitomo Pharma America, Inc.
      Usage: APTIOM is used to treat partial-onset seizures in patients aged 4 years and older.

    • gabapentin

      (Gabapentin)
      Zhejiang Yongtai Pharmaceutical Co., Ltd.
      Usage: Gabapentin is indicated for managing postherpetic neuralgia in adults and as adjunctive therapy for partial onset seizures in adults and pediatric patients aged 3 and older with epilepsy.

    • gabapentin

      (gabapentin)
      Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.
      Usage: Gabapentin capsules are indicated for managing postherpetic neuralgia in adults and as adjunctive therapy for partial onset seizures, with or without secondary generalization, in adults and pediatric patients aged 3 years and older with epilepsy.

    • gabapentin

      (GABAPENTIN)
      Camber Pharmaceuticals, Inc.
      Usage: Gabapentin oral solution is indicated for managing postherpetic neuralgia in adults and for use as adjunctive therapy for partial onset seizures in adults and pediatric patients aged 3 years and older with epilepsy.

    • gabapentin

      (GABAPENTIN)
      Granules Pharmaceuticals Inc.
      Usage: Gabapentin is indicated for managing postherpetic neuralgia in adults and as adjunctive therapy for partial onset seizures in adults and pediatric patients aged 3 years and older with epilepsy.

    • gabapentin

      (gabapentin)
      Advagen Pharma Ltd
      Usage: Gabapentin tablets are indicated for managing postherpetic neuralgia in adults and as adjunctive therapy for partial onset seizures in adults and pediatric patients aged 3 years and older with epilepsy.

    • gabapentin

      (Gabapentin)
      Glenmark Pharmaceuticals Inc., USA
      Usage: Gabapentin tablets are indicated for managing postherpetic neuralgia in adults and as adjunctive therapy for partial onset seizures in adults and pediatric patients aged 3 years and older with epilepsy.

    • lamotrigine

      (Lamotrigine)
      Torrent Pharmaceuticals Limited
      Usage: Lamotrigine extended-release tablets are indicated as adjunctive therapy for primary generalized tonic-clonic seizures and partial-onset seizures in patients aged 13 and older. They can also be used for conversion to monotherapy in those on a single antiepileptic drug. Safety in patients under 13 is未 established.

    • neurontin

      (gabapentin)
      Parke-Davis Div of Pfizer Inc
      Usage: NEURONTIN® is indicated for managing postherpetic neuralgia in adults and as adjunctive therapy for partial onset seizures in adults and pediatric patients aged 3 years and older with epilepsy.

    • neurontin

      (gabapentin)
      Viatris Specialty LLC
      Usage: NEURONTIN® is indicated for managing postherpetic neuralgia in adults and as adjunctive therapy for partial onset seizures, with or without secondary generalization, in adults and pediatric patients aged 3 years and older with epilepsy.